RGNX Latest Press Releases

-- March 5, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in REGENXBIO Inc. of Class Action Lawsuit and Upcoming Deadlines - RGNX PRNewswire 4:59 PM

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages REGENXBIO, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RGNX Globe Newswire 4:45 PM

RGNX'S "TRANSFORMATIONAL" PROMISE BECAME A $2.40 LOSS FOR INVESTORS: SUEWALLST PRNewswire 2:25 PM

REGENXBIO Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights PRNewswire 7:05 AM

-- March 4, 2026 --

UPCOMING DEADLINE: REGENXBIO (RGNX) Securities Fraud Class Action - April 14, 2026 Lead Plaintiff Deadline Globe Newswire 10:37 AM

REGENXBIO Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - RGNX PRNewswire 9:00 AM

REGENXBIO Announces Presentations at the 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference PRNewswire 7:05 AM

-- March 3, 2026 --

ROSEN, NATIONAL TRIAL COUNSEL, Encourages REGENXBIO, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RGNX Newsfile 8:22 PM

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in REGENXBIO Inc. of Class Action Lawsuit and Upcoming Deadlines - RGNX Globe Newswire 2:03 PM

Shareholders that lost money on REGENXBIO Inc.(RGNX) should contact The Gross Law Firm about pending Class Action - RGNX PRNewswire 9:00 AM

-- March 2, 2026 --

REGENXBIO, Inc. Stockholders Have Rights - Stockholders Who Lost Money Investing in RGNX Should Contact Robbins LLP for Information About Recovering Their Losses PRNewswire 5:58 PM

Shareholders that lost money on REGENXBIO Inc.(RGNX) should contact Levi & Korsinsky about pending Class Action - RGNX Globe Newswire 4:00 PM

REGENXBIO to Participate in Upcoming Investor Conferences PRNewswire 7:05 AM

-- March 1, 2026 --

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages REGENXBIO, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RGNX Globe Newswire 7:04 PM

-- February 27, 2026 --

RGNX SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds REGENXBIO (RGNX) Investors of Securities Class Action Deadline on April 14, 2026 PRNewswire 9:20 AM

-- February 26, 2026 --

RGNX Investors Have Opportunity to Lead REGENXBIO, Inc. Securities Fraud Lawsuit PRNewswire 10:06 PM

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against PayPal and REGENXBIO and Encourages Investors to Contact the Firm Globe Newswire 6:36 PM

ROSEN, LEADING INVESTOR COUNSEL, Encourages REGENXBIO, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RGNX Globe Newswire 4:57 PM

Class Action Filed Against REGENXBIO Inc. (RGNX) - April 14, 2026 Deadline to Join - Contact The Gross Law Firm Globe Newswire 4:00 PM

Portnoy Law Firm Announces Class Action on Behalf of REGENXBIO, Inc. Investors Globe Newswire 11:15 AM

-- February 25, 2026 --

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages REGENXBIO, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RGNX Newsfile 9:53 PM

RGNX CLASS ACTION REMINDER: Faruqi & Faruqi, LLP Reminds REGENXBIO (RGNX) Investors of Securities Class Action Deadline on April 14, 2026 Globe Newswire 4:17 PM

Contact Levi & Korsinsky by April 14, 2026 Deadline to Join Class Action Against REGENXBIO Inc.(RGNX) PRNewswire 9:01 AM

REGENXBIO to Host Conference Call on March 5 to Discuss Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights PRNewswire 7:05 AM

-- February 24, 2026 --

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages REGENXBIO, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RGNX Newsfile 9:03 PM

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in REGENXBIO Inc. of Class Action Lawsuit and Upcoming Deadlines - RGNX Globe Newswire 4:46 PM

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 14, 2026 in REGENXBIO Lawsuit - RGNX PRNewswire 9:00 AM

Holzer & Holzer, LLC Reminds RGNX Investors of the April 14, 2026 Lead Plaintiff Deadline in the REGENXBIO Inc. Securities Class Action Globe Newswire 8:00 AM

-- February 23, 2026 --

Contact Levi & Korsinsky by April 14, 2026 Deadline to Join Class Action Against REGENXBIO Inc. (RGNX) Globe Newswire 4:07 PM

-- February 22, 2026 --

ROSEN, LEADING TRIAL ATTORNEYS, Encourages REGENXBIO, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RGNX Newsfile 9:33 PM

-- February 20, 2026 --

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages REGENXBIO, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RGNX Newsfile 10:24 PM

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages REGENXBIO, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RGNX Globe Newswire 6:47 PM

RGNX Stockholder Alert: Robbins LLP Remind Investors of the Class Action Lawsuit Against REGENXBIO, Inc. Globe Newswire 5:11 PM

RGNX Investors Have Opportunity to Lead REGENXBIO Inc. Securities Fraud Lawsuit with the Schall Law Firm Globe Newswire 2:51 PM

REGENXBIO Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - RGNX PRNewswire 4:19 AM

-- February 19, 2026 --

ROSEN, A LONGSTANDING FIRM, Encourages REGENXBIO, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RGNX Newsfile 10:24 PM

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in REGENXBIO Inc. of Class Action Lawsuit and Upcoming Deadlines - RGNX PRNewswire 8:09 PM

Levi & Korsinsky Notifies Shareholders of REGENXBIO Inc.(RGNX) of a Class Action Lawsuit and an Upcoming Deadline Globe Newswire 4:00 PM

RGNX INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds REGENXBIO (RGNX) Investors of Securities Class Action Deadline on April 14, 2026 PRNewswire 2:47 PM

The Gross Law Firm Notifies REGENXBIO Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - RGNX PRNewswire 10:15 AM

-- February 18, 2026 --

Shareholders that lost money on REGENXBIO Inc.(RGNX) Urged to Join Class Action - Contact The Gross Law Firm to Learn More Globe Newswire 5:00 PM

RGNX Stockholder Alert: Robbins LLP Remind Investors of the Class Action Lawsuit Against REGENXBIO, Inc. PRNewswire 4:43 PM

ROSEN, NATIONAL TRIAL LAWYERS, Encourages REGENXBIO, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RGNX Newsfile 4:17 PM

REGENXBIO CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against REGENXBIO Inc. and Encourages Investors to Contact the Firm Globe Newswire 3:23 PM

Shareholders that lost money on REGENXBIO Inc. (RGNX) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More PRNewswire 9:01 AM

-- February 17, 2026 --

RGNX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds REGENXBIO (RGNX) Investors of Securities Class Action Deadline on April 14, 2026 Globe Newswire 2:44 PM

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages REGENXBIO, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RGNX Globe Newswire 2:04 PM

INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of REGENXBIO Inc. (RGNX) Investors - Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm Globe Newswire 12:49 PM

Bronstein, Gewirtz & Grossman LLC Urges REGENXBIO Inc. Investors to Act: Class Action Filed Alleging Investor Harm Globe Newswire 12:00 PM

Portnoy Law Firm Announces Class Action on Behalf of REGENXBIO, Inc. Investors Globe Newswire 10:39 AM

REGENXBIO Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - RGNX Business Wire 7:30 AM

-- February 16, 2026 --

RGNX Investors Have Opportunity to Lead REGENXBIO, Inc. Securities Fraud Lawsuit PRNewswire 7:11 PM

RGNX Investors Have Opportunity to Lead REGENXBIO Inc. Securities Fraud Lawsuit with the Schall Law Firm Business Wire 5:41 PM

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the REGENXBIO, Inc. Securities Class Action Lawsuit Business Wire 2:12 PM

Rosen Law Firm Urges REGENXBIO, Inc. (NASDAQ: RGNX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights Business Wire 1:00 PM

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against REGENXBIO Inc. (RGNX) Globe Newswire 10:54 AM

-- February 13, 2026 --

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of REGENXBIO Inc. Securities and Sets a Lead Plaintiff Deadline of April 14, 2026 Globe Newswire 5:52 PM

-- February 12, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of REGENXBIO Inc. - RGNX PRNewswire 6:51 PM

-- February 9, 2026 --

REGENXBIO Announces Regulatory Update on RGX-121 BLA for MPS II PRNewswire 4:05 PM

-- February 3, 2026 --

RGNX Investors Have Opportunity to Join REGENXBIO Inc. Fraud Investigation with the Schall Law Firm Business Wire 3:06 PM

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of REGENXBIO Inc. - RGNX Globe Newswire 1:57 PM

-- January 29, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of REGENXBIO Inc. - RGNX PRNewswire 7:01 PM

Investigation into Regenxbio: Questions Arise Over Disclosure Completeness Prior to FDA Action PRNewswire 6:06 PM

-- January 28, 2026 --

INVESTOR ALERT: Investigation of REGENXBIO Inc. (RGNX) by Holzer & Holzer, LLC Globe Newswire 2:16 PM

REGENXBIO Announces Regulatory Update on Ultra Rare MPS Programs PRNewswire 7:30 AM

-- January 11, 2026 --

REGENXBIO Highlights Key 2026 Catalysts and Announces Positive Long-Term Functional Outcomes in Lead Duchenne Gene Therapy Program PRNewswire 3:00 PM

-- December 18, 2025 --

REGENXBIO to Present at the 44th Annual J.P. Morgan Healthcare Conference PRNewswire 7:05 AM

-- November 25, 2025 --

REGENXBIO to Participate in Upcoming Investor Conference PRNewswire 7:05 AM

-- November 6, 2025 --

REGENXBIO Reports Third Quarter 2025 Financial Results and Operational Highlights PRNewswire 7:05 AM

-- October 30, 2025 --

REGENXBIO Announces Completion of Pivotal Enrollment and Initiates Commercial Production in Duchenne Gene Therapy Program PRNewswire 7:05 AM

-- October 29, 2025 --

REGENXBIO to Host Conference Call on November 6 to Discuss Third Quarter 2025 Financial Results and Operational Highlights PRNewswire 7:05 AM

-- October 15, 2025 --

REGENXBIO to Participate in Upcoming Investor Conferences PRNewswire 7:05 AM

-- October 9, 2025 --

REGENXBIO Announces Presentation at the American Academy of Ophthalmology 2025 Annual Meeting PRNewswire 7:05 AM

-- October 6, 2025 --

REGENXBIO Announces Completion of Enrollment in Pivotal Trials of Subretinal Surabgene Lomparvovec for Wet AMD PRNewswire 7:05 AM